Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects
Peritoneal carcinomatosis is viewed by many experts as a terminal illness with an unfavourable course and prognosis. Existing therapies are controversial and exhibit ambiguous efficacy.
Sh. Kh. Gantsev+3 more
doaj +1 more source
Textbook outcome in ovarian cancer and its impact on survival: comparative study
Introduction Patients who achieve the textbook outcome (TO) present an uneventful postoperative course. Obtaining TO has also been related to better survival in oncological patients.
Silvia Carbonell-Morote+9 more
doaj +1 more source
Experimental Modeling and Treatment Strategies for Peritoneal Carcinomatosis
Peritoneal carcinomatosis (PC), associated with a range of gastrointestinal and gynecological malignancies, represents a significant condition characterized by the dissemination of cancer cells within the peritoneal cavity.
Aras Emre Canda, Tolga Sever
doaj +1 more source
Exploring the HYDRAtion method for loading siRNA on liposomes : the interplay between stability and biological activity in human undiluted ascites fluid [PDF]
Delivery of small interfering RNA (siRNA) is recently gaining tremendous attention for the treatment of ovarian cancer. The present study investigated the potential of different liposomal formulations composed of (2,3-dioleoyloxy-propyl)trimethylammonium
Braeckmans, Kevin+4 more
core +2 more sources
Managing hydrocephalus in patients with leptomeningeal disease: A multicenter retrospective analysis
What's New? Leptomeningeal disease is a highly palliative condition of tumor cell seeding that can cause symptomatic hydrocephalus. This multi‐center retrospective study of patients with leptomeningeal disease‐associated hydrocephalus compared the placement of ventriculoperitoneal shunts and Rickham reservoirs for cerebrospinal fluid drainage.
Obada T. Alhalabi+19 more
wiley +1 more source
Efficacy of Surgical Treatment of Peritoneal Carcinomatosis in Patients with Colorectal Cancer
Colorectal cancer is one of the most common types of cancer in Ukraine. Prognosis for patients with peritoneal carcinomatosis is unfavorable, and life expectancy is typically less than 6 months.
T G Fetsych, A P Revura
doaj +1 more source
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique [PDF]
Objective: The aim of this study is to present our initial implementation experience in peritoneal carcinomatosis treatment and the technical details of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the light of current ...
Talgat Uskenbayev+4 more
doaj +1 more source
Targeting the tumor microenvironment in colorectal peritoneal metastases
Peritoneal metastasis (PM) occurs in approximately one in four colorectal cancer (CRC) patients. The pathophysiology of colorectal PM remains poorly characterized. Also, the efficacy of current treatment modalities, including surgery and intraperitoneal (
Ceelen, Wim+4 more
core +1 more source
ABSTRACT Background and Objectives Patients with diaphragm tumor deposits undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) require subphrenic peritonectomy (SPP) or full‐thickness diaphragm resection (FTR) to achieve complete cytoreduction.
Claire Liu+4 more
wiley +1 more source
Solitary primary peritoneal carcinoma arising from the omentum
Objective: To report a case of isolated omental peritoneal carcinoma without peritoneal carcinomatosis. Case report: A 60-year-old female with abdominal distention was found to have a pelvic mass.
Yi-Jou Tai+4 more
doaj +1 more source